Klinikum der Universität München (LMU Klinikum)

Corrigendum to “Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of life” [Eur J Cancer 176 (2022) 88–99, (S0959804922005226), (10.1016/j.ejca.2022.08.029)] (2025) Schulz TU, Zierold S, Sachse MM, Pesch G, Tomsitz D, Schilbach K, Kähler KC, et al. Journal article, Erratum Hyperreactive B cells instruct their elimination by T cells to curb autoinflammation and lymphomagenesis. (2025) Diehl C, Soberón V, Baygün S, Chu Y, Mandelbaum J, Kraus L, Engleitner T, et al. Journal article Valgus deformity of the distal tibia in children and adolescents with idiopathic flatfoot: Can it be predicted using 3D movement analysis? (2025) Dussa CU, Dostal N, Böhm H Journal article Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine (2024) Gadelha MR, Casagrande A, Strasburger CJ, Bidlingmaier M, Snyder PJ, Guitelman MA, Boguszewski CL, et al. Journal article Prompt gamma emission prediction using a long short-term memory network (2024) Xiao F, Radonic D, Kriechbaum M, Wahl N, Neishabouri A, Delopoulos N, Parodi K, et al. Journal article Surface-based deep inspiration breath-hold radiotherapy in left-sided breast cancer: final results from the SAVE-HEART study (2024) Schönecker S, Angelini L, Gaasch A, Zinn A, Konnerth D, Heinz C, Xiong Y, et al. Journal article Privacy-friendly evaluation of patient data with secure multiparty computation in a European pilot study (2024) Ballhausen H, Corradini S, Belka C, Bogdanov D, Boldrini L, Bono F, Goelz C, et al. Journal article CCL22 as an independent prognostic factor in endometrial cancer patients (2024) Mannewitz M, Kolben T, Perleberg C, Meister S, Hahn L, Mitter S, Schmoeckel E, et al. Journal article Targeted RT study: results on early toxicity of targeted therapies and radiotherapy (2024) Konnerth D, Gaasch A, Westphalen CB, Heinrich K, Niyazi M, Eze C, Rogowski P, et al. Journal article Factors influencing pathological complete response and tumor regression in neoadjuvant radiotherapy and chemotherapy for high-risk breast cancer (2024) Haussmann J, Budach W, Nestle-Krämling C, Wollandt S, Jazmati D, Tamaskovics B, Corradini S, et al. Journal article